anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
OmniAb · pitchdeck

OmniAb | SPAC Presentation Deck | 35 slides

35 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

OmniAb | SPAC Presentation Deck | 35 slides

OmniAb · 2022-03
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 20 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
100% 1/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Solution 6 slides 100% 6/6 slides 100% 6/6 slides · 33 hits
— 0/6 slides
— 0/6 slides
50% 3/6 slides 100% 6/6 slides
— 0/6 slides
Business Model 12 slides 100% 12/12 slides 100% 12/12 slides · 63 hits
— 0/12 slides
50% 6/12 slides · 7 hits 33.3% 4/12 slides 100% 12/12 slides 8.3% 1/12 slides

Slide inventory

35
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
other
Open slide detail
04
The slide uses a 3-row comparison matrix (Track Record, Platform, People) to justify a strategic partnership or merger.compare_peers
Open slide detail
05
The slide uses a split-layout to contrast the specific asset (OmniAb) with the broader investment firm (Avista Capital Partners) and its portfolio companies.establish_context
Open slide detail
06
Details a SPAC merger transaction structure.analyze_data
Open slide detail
07
The chart categorizes peers into three groups: Diversified Drug Discovery, Computationally-Enabled Drug Discovery, and Next-Generation Discovery and Production compare_peers
Open slide detailBeat · Market Size
08
The slide uses a color-coded horizontal layout to distinguish between the two leadership teams and the board nominees.other
Open slide detail
09
transition
Open slide detail
10
The chart is a radial dot plot representing drug development stages across different technology platforms.establish_context
Open slide detail
11
The slide uses a combination of market sizing, comparative success rates, and regulatory approval trends to justify the business opportunity.argue_timing
Open slide detailBeat · ProblemLoop · Golden Circle
12
The slide uses a timeline to establish credibility and demonstrate long-term R&D commitment.show_traction
Open slide detail
13
The slide uses two pie charts to illustrate the expansion of the pipeline from 21 to 252 programs.show_traction
Open slide detail
14
The slide uses a process flow diagram to explain the core technology steps.present_solution
Open slide detailBeat · Solution
15
The slide uses a value-chain style process flow to map specific proprietary technologies to stages of antibody discovery.present_solution
Open slide detailBeat · Solution
16
The slide highlights a multi-species platform approach for antibody discovery.present_solution
Open slide detailBeat · Solution
17
The slide highlights two core technologies and mentions a future iteration, xPloration 2.0.present_solution
Open slide detailBeat · Solution
18
The slide uses a process-flow chevron graphic at the top to indicate the current stage in the pipeline.present_solution
Open slide detailBeat · Solution
19
The slide uses a process flow diagram to illustrate the antibody discovery workflow.present_solution
Open slide detailBeat · Solution
20
present_solution
Open slide detailBeat · Business Model
21
The chart shows a clear upward trend in patent filings from 2014 to 2021.present_solution
Open slide detailBeat · Business Model
22
show_traction
Open slide detailBeat · Business Model
23
The slide uses a 4-column layout to contrast different partner profiles (Emerging Biotech, Big Pharma, Established Biotech, Global Pharma) and their specific chillustrate_case
Open slide detailBeat · Business Model
24
The chart uses a horizontal bar representation to show the progress of each drug candidate across clinical phases.show_traction
Open slide detailBeat · Business ModelLoop · Cost Of Inaction
25
The table uses a qualitative checkmark system to compare technological capabilities, suggesting a proprietary assessment.compare_peers
Open slide detailBeat · Business Model
26
other
Open slide detailBeat · Business Model
27
transition
Open slide detailBeat · Business Model
28
The slide uses a dark background with antibody imagery, emphasizing the core business model of royalty-based revenue.summarize
Open slide detailBeat · Business Model
29
The charts demonstrate a clear upward trend in key business metrics, supporting the claim of a highly scalable business model.show_traction
Open slide detailBeat · Business Model
30
Uses a simple additive framework (Current Portfolio + Pipeline Development = Value Drivers).present_framework
Open slide detailBeat · Business Model
31
The slide emphasizes flexibility in deal structures while maintaining long-term value for OmniAb.present_solution
Open slide detailBeat · Business Model
32
appendix
Open slide detail
33
Slide tracks key milestones for a specific drug asset.show_traction
Open slide detail
34
show_traction
Open slide detail
35
This is a standard closing slide with a call to action to visit the company website.state_next_steps
Open slide detail